Cryoport, Inc.
CYRXNASDAQIndustrials● Active
$15.48
$-0.22(-1.40%)
Market Cap$780227604
P/E Ratio—
52W High$16.7
52W Low$6.05
Cryoport, Inc.（CYRX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CYRX · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.18B | $0.23B | $0.24B | $0.22B | $0.22B |
| Cost of Revenue | $0.09B | $0.13B | $0.13B | $0.13B | $0.13B |
| Gross Profit | $0.08B | $0.10B | $0.10B | $0.10B | $0.10B |
| Gross Margin %(computed) | 47.14% | 42.59% | 43.78% | 43.38% | 43.38% |
| Operating Expenses | |||||
| R&D Expenses | $0.02B | $0.02B | $0.02B | $0.02B | $0.02B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.12B | $0.21B | $0.14B | $0.11B | $0.11B |
| Operating Income | ($0.04B) | ($0.12B) | ($0.03B) | ($0.02B) | ($0.02B) |
| Operating Margin %(computed) | -20.89% | -49.37% | -13.45% | -8.01% | -8.01% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.01B | $0.01B | $0.00B | $0.00B |
| Income Before Tax | ($0.03B) | ($0.10B) | ($0.04B) | ($0.27B) | ($0.27B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.08B | ($0.10B) | ($0.04B) | ($0.28B) | ($0.28B) |
| Net Margin %(computed) | 44.44% | -42.69% | -15.73% | -123.77% | -123.77% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.40 | $-2.21 | $-0.93 | $-6.18 | $-6.18 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| EBITDA | ($0.00B) | ($0.07B) | ($0.01B) | ($0.25B) | ($0.25B) |
| EBITDA Margin %(computed) | -1.19% | -28.45% | -2.61% | -111.81% | -111.81% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Cryoport, Inc.
关于Cryoport, Inc.（CYRX）损益表
Cryoport, Inc.（CYRX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CYRX实现营收$0.18B，毛利润$0.08B（毛利率47.14%），净利润$0.08B（净利率44.44%）。
常见问题
CYRX · 4 问Cryoport, Inc.（CYRX）2025财年营收为$0.18B，同比down24.5%。
CYRX revenueCYRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08